Whipplewood Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66K Sell
7
-515
-99% -$107K ﹤0.01% 463
2026
Q1
$110K Buy
522
+422
+422% +$90.9K 0.06% 175
2025
Q4
$20.6K Hold
100
0.01% 248
2025
Q3
$15.7K Sell
100
-150
-60% -$23.2K 0.01% 256
2025
Q2
$42K Buy
250
+44
+21% +$6.53K 0.02% 350
2025
Q1
$21.4K Buy
206
+51
+33% +$6.5K 0.01% 442
2024
Q4
$18.3K Buy
+155
New +$18.1K 0.01% 455

Other funds holding CAH

Whipplewood Advisors's CAH Position: Q2 2026 in Review

Whipplewood Advisors reduced its Cardinal Health (CAH) stake by 99% in Q2 2026, selling an estimated $107K and leaving 7 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Whipplewood Advisors first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. The position peaked at $110K in Q1 2026. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Whipplewood Advisors held 7 shares of Cardinal Health worth $1.66K as of Q2 2026.
  • Whipplewood Advisors sold 515 Cardinal Health shares in Q2 2026, an estimated $107K.
  • Cardinal Health made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #463 holding.
  • Whipplewood Advisors first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • Whipplewood Advisors's Cardinal Health position peaked at $110K in Q1 2026.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.